Additional Drug Resistance in Patients with Multidrug-resistant Tuberculosis in Korea: a Multicenter Study from 2010 to 2019.
Taehoon LeeSeung Jun LeeDoo Soo JeonHo Young LeeHyo Jung KimBo Hyoung KangJeong Ha MokPublished in: Journal of Korean medical science (2021)
The proportions of new patients and rates of additional drug resistance in patients with MDR-TB were high and remain stable in South Korea. A nationwide analysis of DRS data is required to provide effective treatment for MDR-TB patients in South Korea.
Keyphrases
- multidrug resistant
- end stage renal disease
- chronic kidney disease
- mycobacterium tuberculosis
- ejection fraction
- peritoneal dialysis
- prognostic factors
- emergency department
- machine learning
- pseudomonas aeruginosa
- gram negative
- electronic health record
- deep learning
- cystic fibrosis
- patient reported
- pulmonary tuberculosis
- replacement therapy